theory clinical_65_0
imports Main

begin

typedecl entity
typedecl event

consts
  Akt :: "entity ⇒ bool"
  FullyActivated :: "entity ⇒ bool"
  Mediates :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  CellularFunctions :: "entity ⇒ bool"
  Include :: "entity ⇒ entity ⇒ bool"
  Proliferation :: "entity ⇒ bool"
  Survival :: "entity ⇒ bool"
  Alpelisib :: "entity ⇒ bool"
  KinaseInhibitor :: "entity ⇒ bool"
  Used :: "event ⇒ bool"
  Treatment :: "entity ⇒ bool"
  BreastCancers :: "entity ⇒ bool"
  In :: "entity ⇒ entity ⇒ bool"
  Mutations :: "entity ⇒ bool"
  PI3K_AKT_Pathway :: "entity ⇒ bool"
  Target :: "event ⇒ bool"
  Inhibit :: "event ⇒ bool"

(* Explanation 1: Fully activated Akt mediates numerous cellular functions including proliferation and survival. *)
axiomatization where
  explanation_1: "∃x e y z w. Akt x ∧ FullyActivated x ∧ Mediates e ∧ Agent e x ∧ Patient e y ∧ CellularFunctions y ∧ Include y z ∧ Proliferation z ∧ Include y w ∧ Survival w"

(* Explanation 2: Alpelisib is a kinase inhibitor used in the treatment of certain breast cancers. *)
axiomatization where
  explanation_2: "∃x y z e w. Alpelisib x ∧ KinaseInhibitor y ∧ Used e ∧ Agent e y ∧ Patient e x ∧ Treatment w ∧ BreastCancers z ∧ In z w"

theorem hypothesis:
  assumes asm: "KinaseInhibitor x ∧ Mutations y ∧ PI3K_AKT_Pathway z"
  (* Hypothesis: Using a kinase inhibitor may target mutations in the PI3K/AKT pathway and inhibit proliferation and survival. *)
  shows "∃x y z e1 e2. KinaseInhibitor x ∧ Mutations y ∧ PI3K_AKT_Pathway z ∧ Target e1 ∧ Agent e1 x ∧ Patient e1 y ∧ In y z ∧ Inhibit e2 ∧ Agent e2 x ∧ Patient e2 Proliferation ∧ Patient e2 Survival"
  sledgehammer
  oops

end
